Abstract Carrier testing is widely available for multiple genetic conditions, and several professional organizations have created practice guidelines regarding appropriate clinical application and the testing of minors. Previous research has focused on carrier screening, predictive testing, and testing for X-linked conditions. However, family perspectives on carrier testing for X-linked lethal diseases have yet to be described. In this study, we explored communication within the family about carrier testing and the perspectives of mothers of sons with an X-linked lethal disease, Duchenne muscular dystrophy (DMD). Twenty-five mothers of sons with DMD participated in an anonymous online survey. Survey questions included multiple choice, Likert scale, and open ended, short answer questions. Analysis of the multiple choice and Likert scale questions revealed that most mothers preferred a gradual style of communication with their daughters regarding risk status. In addition, most participants reported having consulted with a genetic counselor and found it helpful. Comparisons between groups, analyzed using Fisher's exact tests, found no differences in preferred style due to mother's carrier status or having a daughter. Thematic analysis was conducted on responses to open ended questions. Themes identified included the impact of family implications, age and maturity, and a desire for autonomy regarding the decision to discuss and undergo carrier testing with at-risk daughters, particularly timing of these discussions. Implications for genetic counseling practice are discussed.
Introduction
Duchenne muscular dystrophy (DMD) is an X-linked, multisystemic neuromuscular disease, affecting 1 in 3600 live male births each year (Emery 1991) . Affected individuals experience degeneration of cardiac and skeletal muscle. The first symptoms of the disease are delayed motor milestones and Gowers' sign; individuals typically become wheelchair dependent before their teenage years. Respiratory and cardiac decline are the most lethal features of DMD. Individuals experience a decline of respiratory function between 9 and 11 years of age and cardiac complications emerge in their late teenage years (Biggar 2006) . Average life expectancy is 27 years of age with the use of ventilation (Rall and Grimm 2012) . Currently there is no cure for DMD and available treatments may serve to only slow the disease progression (Darras et al. 2014) .
DMD is caused by mutations in the dystrophin gene (DMD) located at Xp21.2 that result in an absence of the protein dystrophin, leading to muscle degradation (Boyd and Buckle 1986; Burghes et al. 1987; Hopkins 2006; Koenig et al. 1987; Monaco et al. 1986 ). Female carriers rarely show symptoms of DMD except in cases of a translocation or skewed X-inactivation; however, 10-15 % of female carriers experience heart complications at some point during their lifetime (Hoogerwaard et al. 1999; Song et al. 2011) .
Carrier Testing for Duchenne Muscular Dystrophy
Carrier testing is available for individuals who are at risk of being a carrier for DMD. The standard method for carrier testing is multiplex ligation-dependent probe amplification (MLPA) whether testing for a known familial mutation (Bushby et al. 2010) or in the absence of a known mutation (Verma et al. 2012) .
Carrier Testing of Minors
Genetic testing of minors raises ethical and legal concerns regarding the psychological and social harms of knowing certain genetic information, the autonomy of minors, and the possibility that minors may not be cognitively or emotionally capable of assessing the risks and benefits of genetic testing (McConkie-Rosell and Spiridigliozzi 2004) . In 2013, the American Academy of Pediatrics (AAP) and the American College of Medical Genetics (ACMG) released a joint policy statement regarding genetic testing and screening of children (Ross et al. 2013) . They recommended that genetic testing of minors is appropriate if there are health benefits during childhood or if an adolescent is pregnant or considering reproduction. Genetic testing of a minor is generally not considered appropriate when testing is motivated by curiosity or parental wishes.
Despite these guidelines, adolescents, families, and healthcare providers are often involved in discussions determining if genetic testing of a minor is appropriate. Genetic counselors are essential in helping balance the guidelines and ethical principles while accounting for social aspects within the family (American Society of Human Genetics Board of Directors and American College of Medical Genetics Board of Directors 1995). To prevent conflict and promote family and individual autonomy, it is important for genetic counselors to understand and incorporate the perspectives of the minor facing testing, their parents, and siblings into the genetic counseling session.
Family Perspectives on Carrier Testing
The literature on genetic testing of minors and young adults has focused on many areas of clinical genetics, including neurodegenerative conditions such as Huntington's disease, and inherited cardiovascular and cancer syndromes. Duncan et al. (2007) explored the outcomes of young adults who underwent asymptomatic testing for Huntington's disease. These researchers found young adults felt that not knowing their status was a barrier in their life and testing allowed them to move forward with their lives in a positive way. They reported that none of their participants regretted undergoing testing.
With medical intervention available for adolescents, long QT syndrome (LQTS) meets the guidelines for genetic testing of minors. A study conducted in 2012 explored the challenges of genetic testing for this condition and found parents were hesitant to disclose that they had the condition to their children (Cohen et al. 2012) . Parents were concerned that their adolescent child may lack the maturity and ability to psychologically cope with the information. This study highlights not only parental concern for genetic testing in minors, but also the complex factors that parents incorporate into their decision to disclose or not disclose genetic risk.
Another condition with medical intervention recommended in childhood is familial adenomatous polyposis (FAP). This inherited cancer syndrome can begin manifesting in childhood and guidelines suggest beginning surveillance at 10 years of age. Levine et al. (2010) explored parental attitudes related to genetic testing and found parents believed that genetic testing for their children was appropriate given the increased risk for childhood cancers and published screening guidelines. Reasons parents did not seek out or wish to have testing for their children were focused on misinformation regarding genetic mutations, insurance coverage, and lack of health care provider recommendation for testing (Levine et al. 2010) . These findings highlight the importance of genetic counseling to provide accurate and clear information to patients.
To date, studies of family members' attitudes regarding carrier testing for an X-linked condition in a minor seem to favor testing before the age of 18 years only when the child is competent to understand and emotionally cope with the results (James et al. 2003; Wehbe et al. 2009 ).
Communication of Genetic Risk
Genetic counselors play an important role in educating families about genetic conditions, yet it is generally assumed, by families and health care professionals, that families are responsible for disclosing genetic risk information to their children (Borry et al. 2006) . Forrest et al. (2003) explored perspectives of families with hereditary breast and ovarian cancer (HBOC) syndrome or Huntington's disease (HD) regarding who should communicate genetic risk information to at-risk family members. They found that families with HBOC syndrome or HD believed it is the responsibility of the family to disclose genetic risk information, not health care professionals (Forrest et al. 2003) . Results suggested that health care professionals do have a role to play in helping families with disclosure either through a subsequent counseling session with the affected individual, joint sessions to facilitate disclosure, or through providing informational material to families.
Just as genetic counselors should incorporate the perspectives and needs of families into counseling regarding carrier testing, it is important for genetic counselors to be aware of the way families think and feel about discussing genetic information with their children. Parents struggle with concerns of disclosing information too early, when a child may not be ready, or disclosing information too late, when the child may feel as though they were lied to (Rowland and Metcalfe 2013) . As parents determine the right time to disclose genetic information to their child, they also deal with anxiety and guilt as they are faced with discussing a diagnosis that was once difficult to hear themselves (Etchegary and Fowler 2008; Klitzman et al. 2007; Plumridge et al. 2011) . Several studies have demonstrated that parents' disclosure occurs over time with an open flow of communication, yet centered on major life events such as their child's sixteenth birthday, graduation from high school, or marriage; or when their daughter becomes pregnant (Etchegary and Fowler 2008; Klitzman et al. 2007; Plumridge et al. 2011 ). Forrest et al. (2003 explored the style of communication within families with HBOC syndrome or HD and found that both groups struggled with determining the right time to disclose genetic risk to their children; but they felt that it should be disclosed prior to the children making key life decisions such as marriage or having children. Timing of disclosure before key life events was more of a concern for individuals from families with HD, and researchers assumed this was due to the penetrance and severity of HD compared to HBOC syndrome. Additionally, families with HD reported more anxiety about disclosing genetic risk information, presumably because there is no medical intervention for HD. This suggests that family perspectives may differ with respect to the nature of the genetic condition within the family.
Prior research in non-lethal X-linked conditions, specifically fragile X syndrome, has indicated that families tend to favor an open style of communication, giving information in stages, with information becoming more detailed as children mature (Wehbe et al. 2009 ). Adolescents in these families believe they are more perceptive, with better capacity to understand and cope, than their parents may appreciate. As described in their meta-analysis review, Wilson et al. (2004) found that the communication process is affected by multiple factors, including the nature of the disease, whether preventative measures were available and the overall pattern of family communication and coping styles (Wilson et al. 2004) . Therefore, findings from previous studies on family disclosure for other genetic conditions may not be generalizable to an X-linked lethal condition, such as DMD.
Purpose of the Study
Previous research has focused on carrier screening, predictive testing, and testing for both autosomal and X-linked conditions. However, family perspectives on carrier testing for Xlinked-lethal disorders have yet to be described. In this study, we explored communication within the family about carrier testing and the perspectives of mothers of sons with an Xlinked lethal disease, Duchenne muscular dystrophy.
Methods

Participants and Procedures
This study was approved by the University of Oklahoma Institutional Review Board (#3138). Individuals over the age of 18 years with a family history of DMD or parents of a son diagnosed with DMD were invited to participate. All participants were English speaking. Participants were recruited between November 2013 and February 2014 using an informational flyer posted to online support groups, social networking sites, and an online magazine. Participants were informed that the purpose of the study was Bto broaden the understanding of medical professionals on the perspectives of individuals with a family history of Duchenne muscular dystrophy on carrier testing and better understand how they discuss Duchenne muscular dystrophy within their family.Î nstrumentation An online survey, using Qualtrics survey software (Qualtrics, Provo, Utah USA, 2009) accessed through the University of Oklahoma Health Sciences Center, was developed using current policy guidelines from the American Academy of Pediatrics and the American College of Medical Genetics, as well as using knowledge obtained from prior findings (James et al. 2003; Ross et al. 2013; Wehbe et al. 2009 ). Based on these prior studies, a 42 question survey was created by the authors that included open-ended, free response questions, multiple choice questions, and Likert scale questions. Prior to finalizing the online survey, feedback was solicited from University of Oklahoma Health Sciences Center Masters in Genetic Counseling graduate students and survey questions and format were refined based on their responses.
Likert scale responses were: BStrongly agree,^BAgree,B Neutral,^BStrongly disagree,^and BDisagree,^or BVery Important,^BSomewhat Important,^BNeutral/Uncertain,B Somewhat Unimportant,^and BVery Unimportant,^depend-ing on the context of the question. The survey was designed to branch depending on participant response. As a result of this design, the number and content of the questions varied from one participant group to another. For example, participants who had carrier testing themselves were asked additional questions about their experience with carrier testing, while those who had not had carrier testing were not asked those questions.
Data Analysis
Qualitative Data Analysis
Answers to free response questions were analyzed by the first author using thematic analysis, searching text for codes, and then categorizing these codes into themes (Braun and Clarke 2008) . To validate the themes identified, a second researcher, the last author, followed the same steps to analyze the data, and the researchers then compared their categorizations to refine and determine the common themes (Braun and Clarke 2008) . Themes were further refined to identify any subthemes that emerged from the data. As Braun and Clarke (2008) describe, sub-themes are Bessentially themes-withina-theme^. Overarching themes were defined as themes that emerged across multiple questions, seen across the survey as a whole.
Quantitative Data Analysis
Group descriptive statistics were expressed as mean±standard deviation and grouped frequencies. Fisher's exact tests for small samples were used to compare participant groups: mothers with daughters vs. mothers without daughters, and carriers vs non-carriers on factors for deciding when to talk to a minor daughter about DMD, her carrier risk and carrier testing (see Table 2 ). For the Fisher's exact tests the Likert scale responses were collapsed to Bagree^("Strongly agree", "Agree") vs "did not agree" ("Neutral", "Disagree", "Strongly disagree"). BNeutral^responses were grouped with Bdid not agree^for analysis as they were considered as not agreeing with the statement. Data analyses were conducted using IBM SPSS Statistics (IBM Corp. 
Results
Participant Characteristics
Twenty-five mothers of boys who had DMD completed the online survey. Sixteen of these also had at least one daughter. Twenty-one women had been tested for carrier status and 17 were carriers for DMD. Mothers ranged in age from 29 to 57 years and most (22/25) described themselves as Caucasian. Additional participant information is shown in Table 1 . One father and three additional respondents, who were both mother and sister to family members with DMD, were excluded in the interest of homogeneity of the sample.
Thematic analysis of open-ended questions
Two themes and one sub-theme were extracted from responses to the question, "Tell me what you feel the advantages and disadvantages are to undergoing carrier testing prior to the age of 18." Theme #1: Ability to make informed decision regarding available reproductive options given teenage pregnancy rates:
"As we all know, as much as we want our daughters to save themselves for marriage girl [sic] are having "…she is only 8 so details are not important at the moment." (Participant #14)
There was one theme identified in responses to the question, BIf you were to give another parent advice about talking to their daughter, what would you say to them?T heme #1: Being honest:
"Always be open from the begging [sic] ." (Participant #1) The question, BTell me why you did or did not feel discussing carrier testing with a genetic counselor was helpful^, yielded one theme and one sub-theme.
Theme #1: Individuals gained insight and understanding:
B…It helped clarify things.^(Participant #22) Sub-theme #1: Autonomy:
BThey decide for you about whom you should test, age of consent etc.…every family is different and I think that kind of info should be given when the family thinks it's time, the genetic counselor has no idea about this…genetic counselor gave me nothing but heartache.^(Participant #14)
Overarching Themes
Three overarching themes were identified in participant responses to all open-ended questions. They included the impact of family implications, age and maturity, and a desire for autonomy on the decision to discuss and undergo carrier testing with at-risk daughters.
Familial Implications
Participants who themselves had carrier testing indicated that age was not a factor in deciding when to have carrier testing. Instead, participants sought carrier testing because of familial implications, such as risk of recurrence and identifying other family members who may be at risk:
BI knew I wanted more children, but did not want to risk having more children until I knew whether or not I was a carrier.^(Participant #8) BI wanted to know if I was a carrier because I have a daughter that would need to be tested.^(Participant #9)
When specifically asked about their perspective regarding carrier testing under the age of 18 years, mothers indicated that they felt an advantage was the ability to make informed decisions regarding available reproductive options given current teenage pregnancy rates. Mothers commented on their own struggles of having a son with DMD and thought if they had known earlier, they may have made different reproductive decisions:
B….Had I known, I would have adopted, or had this special in vitro that exists to avoid the condition [sic] ir maybe not had kids. I 100 % do not regret having my boys, [sic] iI live them and would my life for them if I could to make them well. But had I known I would have had more options that maybe would have been leas [sic] hurtful for all of us.^(Participant #16) "….most kids are sexually active before 18 and having a child with Duchennes is life changing…." (Participant #5) Familial implications included identifying other family members who may be at risk, including concern for health risks:
B…heart complications should be considered.^(Participant #19)
Age and Maturity
Participants reported the disadvantage to having carrier testing prior to the age of 18 years was the maturity of minors to handle the results of carrier testing:
B…not mature enough to handle possible negative results.^(Participant #8)
Participants were asked open ended questions about additional factors that were important concerning when to talk to their daughter about DMD and her carrier risk. Age and maturity emerged as a theme in their responses:
B…be cautious on how much the child is exposed to as to not put any undue stress on them…open communication should be #1 keeping in mind the level of maturity of the child…^ (Participant #1) When asked what difficulties they faced when talking with their daughter about DMD, participants indicated that they did not experience difficulty. A sub-theme noted was that parents were concerned about creating a safe and supportive environment for the discussion in order to eliminate psychological stress on their daughter and that the parents were concerned about how their children might react:
B…we are honest and loving with our responses…( Participant #14) When asked to provide advice to another parent about talking to their daughter, honesty was identified as a theme: 
Autonomy
When asked why they did or did not find genetic counseling helpful, mothers indicated that genetic counseling helped them gain insight and understanding about DMD, the genetic causes of DMD, who else in the family may be at risk for being a carrier for DMD, and what the risks of recurrence were:
BIt helped me to understand what the testing ment [sic] for me and my daughter.^(Participant #17) "I had never heard of this disease before so I had millions of questions, our counselor was very helpful!" (Participant #5) However, a desire for autonomy also emerged as a theme, both in the timing of testing and the decision of whether or not to have carrier testing:
BI feel very strongly about this should be done ASAP and the results given to our daughter when we feel it is right not some cold clinical genetics counselor.^(Participant #14) B…refuses to do carrier testing on anyone under 18. They also do not do testing without seeing the genetic counselor. This irritates me as I think you should be able to have the test and choose if you would like to speak to a genetic counselor.^(Participant #24)
Quantitative Analysis
Fisher's exact tests were used to compare mothers with daughters (n=16) vs. mothers without daughters (n=9) and carriers (n=11) vs. non-carriers (n=3) on factors for deciding when to talk to a minor daughter about DMD, her carrier risk and carrier testing (see Table 2 ). There were no significant differences in proportions of agreement/disagreement for either of these group comparisons for any of the seven factors (Table 2) . To put this into perspective, with a sample size of 25 we have over 90 % power to detect a difference in proportions of 0.8 vs 0.3. However, this drops to just over 50 % power if the proportions are 0.6 vs 0.3 (Dobson and Gebski 1986) . Our observed proportions are closer to the latter so the failure to find significant differences may be due to low power.
Disclosing Disease Information
Mothers were asked whether or not they had discussed the possibility of being a carrier with their daughter and at what age that discussion occurred. Ten of sixteen participants indicated they had discussed carrier risk with their daughter; however, the majority of mothers could not identify a specific age at which the discussion occurred (Table 1) .
Participants were asked to select their style of communication and six of ten responded with gradual style of communication (shared information with vague details beginning at a young age and subject matter gradually became detailed as the daughter aged) ( Table 1) . Participants were also asked to rate the level of importance of the following eight factors when deciding when to talk to their daughter about DMD and her risk of being a carrier: 1) her age, 2) her emotional maturity, 3) her understanding of biology and genetics, 4) her exposure to DMD (witnessing the symptoms or treatment of a male with DMD), 5) her interest in learning more, 6) your personal relationship with your daughter, 7) your personal level of comfort with your understanding of how DMD is inherited, 8) your personal level of comfort with your ability to explain how DMD is inherited. Participants overwhelmingly rated these factors as either Bsomewhat important^or Bvery important( 76 of 88 ratings).
Participation in Genetic Counseling
Participants were asked to answer whether or not they had seen a genetic counselor to discuss carrier testing and whether Family Perspectives on DMD Carrier Testingor not they found genetic counseling to be helpful (Table 1) . Seventeen of the nineteen mothers who had genetic counseling found it helpful. Mothers reported receiving most of their support through medical professionals (including genetic counselors) and internet searches when preparing to talk to their daughters (14 responses with 6 indicating medical professionals, 5 genetic counselors, and 4 internet searchesmultiple selections could be made).
Discussion
In this study, we explored communication within the family about carrier testing and the perspectives of 25 mothers of sons with an X-linked-lethal disorder, Duchenne muscular dystrophy (DMD). Three overarching themes: age and maturity, familial implications, and autonomy, emerged from participant responses. Interpretation of the results and implications for genetic counseling practice are discussed in the following sections, followed by study limitations and research recommendations.
Age and Maturity
Age and maturity were themes identified in determining when to have carrier testing, when to discuss carrier testing, and what type of information to disclose when communicating information about carrier risk and DMD. Recent guidelines published by the American Academy of Pediatrics and the American College of Medical Genetics recommend delaying carrier testing until after the age of 18 unless the minor is pregnant, is considering reproduction, or there is medical intervention or surveillance available (Ross et al. 2013) . Recommendations are based on the minor's ability to emotionally cope with the information (Borry et al. 2006) , which was a concern raised by participants in this study. Participants indicated that the age and maturity of their daughter is important because having a child with DMD presents challenges and knowing risk status could be emotionally difficult. Prior studies of families with fragile X syndrome also reflect the importance of appropriate timing of testing based on maturity and individual needs of the child and the child's family (Wehbe et al. 2009 ). The present findings are also consistent with findings from prior studies on testing for LQTS, which found that families worried about the maturity of their children and their ability to psychologically cope with risk information based on the nature of the condition (Cohen et al. 2012) . Findings from our study suggest that families prefer an open and honest form of communication where they share information with their daughters from a young age, tailoring the content and detail to the age of the child. These findings are consistent with communication patterns in families with HD and fragile X syndrome in which both parents and children favor information being communicated throughout the child's life (Forrest et al. 2003; Wehbe et al. 2009 ).
Additionally, our study and previous studies indicate that disclosure of risk information often occurs around major life events (Etchegary and Fowler 2008; Klitzman et al. 2007; Plumridge et al. 2011) . Thus, the findings in this study are consistent with those found for other genetic conditions. This suggests that age and maturity are factors which influence family communication of risk across disease types.
Familial Implications
The mothers in our study reported that carrier testing was important to identify family members who are at risk, to make decisions regarding their personal reproductive choices, and to allow their daughters to make reproductive decisions. Participants indicated that knowledge of their own carrier status would have been helpful in making reproductive decisions. Several prior studies suggest timing of disclosure of carrier status is based on major life events, such as pregnancy or family planning (Etchegary and Fowler 2008; Klitzman et al. 2007; Plumridge et al. 2011 ). While our findings are from adult mothers, they are consistent with findings from young adults in families with fragile X syndrome, who felt that knowing carrier status was important for reproductive decision making (Wehbe et al. 2009 ). This suggests that knowing their carrier status is a priority for women of various ages when considering reproduction. However, previous research regarding the reproductive patterns of women with a previous child diagnosed with DMD or Becker muscular dystrophy (BMD) indicated they did not differ significantly in reproductive choices from women who did not have a son diagnosed with either condition (Nabukera et al. 2013) . Additional research exploring reproductive choices of carriers identified by genetic testing prior to the age of 18 years would provide insight into the impact of carrier testing of minors on reproductive options.
Mothers in our study indicated that carrier testing prior to age 18 years was advantageous for the reproductive decision making of their teenage daughters. The rate of teenage pregnancy is currently 31.3 live births per 1000 women 15-19 years of age (Hamilton et al. 2012 ) and parents are aware that their daughters may be sexually active prior to the age of 18. Mothers in this study wanted their daughters to hear about all the reproductive options available to them and expressed that carrier testing would provide an opportunity for their daughters to gain knowledge and think through options should they become pregnant. Again, this finding is consistent with the perspectives of young adult females from families with fragile X syndrome (Wehbe et al. 2009 ).
Autonomy
Our study found that mothers favored autonomy in deciding when they, and their daughters, should have carrier testing and when to discuss carrier testing with their daughters. The desire for autonomy when discussing carrier testing is consistent with previous studies in families with HBOC syndrome or HD (Forrest et al. 2003) , as well as published guidelines for carrier testing of minors (Borry et al. 2006) . Families with HBOC syndrome or HD found health care professionals to be helpful when determining when and how to disclose genetic risk information. Results of our study are similar in that some mothers felt genetic counseling was helpful in gaining more information, but our findings differ from those of previous studies in that some mothers found genetic counseling to be a barrier to testing and communication with their family. Forrest et al. (2003) reported that families found support for communication from health care professionals through the facilitation of written information or coordinated counseling sessions. Our study also found that mothers received most of their support through medical professionals (including genetic counselors) and internet searches when preparing to talk to their daughters. However, our study did not expand on the ways that medical professionals were of use to mothers. Future studies should explore how genetic counselors could better support mothers during their communication of genetic risk and carrier testing with their daughters.
Summary
As noted earlier, whether the mother had a daughter or not and whether the mother knew she was a carrier or non-carrier did not associate with significant differences in preferred style of communication as measured by seven factors for deciding when to talk to a minor daughter about DMD, her carrier risk and carrier testing. While a clear caveat is that the statistical power for these comparisons is probably low because of the small sample size, we would point out that, on perfunctory inspection, large differences in preferred style were not apparent.
Previous research on the disclosure of genetic risk suggests that family perspectives may differ with respect to the severity and available interventions for the genetic condition in the family (Forrest et al. 2003; Wilson et al. 2004) . Families with fragile X syndrome have previously been found to favor an open style of communication, giving information in stages, with information becoming more detailed over time (Wehbe et al. 2009 ). Our study focused on an X-linked lethal disease, Duchenne muscular dystrophy (DMD), to explore if the severity of the X-linked condition would impact communication regarding risk status within the family. Both fragile X syndrome and DMD are Xlinked, resulting in the focus of risk being placed on the mother and the sister of the affected individual. However, prior research suggested that the difference in severity may impact family communication. Our findings were similar to those previously found in families with fragile X syndrome, preferring an open style of communication, giving information in stages, increasing details over time. Timing of information and carrier testing around major life events, such as pregnancy, was similar to that described in families with Huntington's disease (HD). However, the increased anxiety described in families with HD was not identified in our study. Instead, autonomy was an identified theme, impacting communication within the family and with health care providers. Thus, while family communication was similar to that reported in previous studies on X-linked conditions, additional factors impacting family communication were identified.
Practice Implications
Genetic counselors must balance ethics and social aspects of the family when discussing carrier testing with individuals. When health care professionals do not strike a balance between these two, conflict may arise within the session (McConkieRosell and Spiridigliozzi 2004) . Conflict may have a significant impact on the counselor-patient relationship and the future opportunity to support a family during the carrier testing process. Based on the identified themes of this study, genetic counselors should be aware of the desire for autonomy by mothers of girls who may be DMD carriers. Additionally, counselors should explore ways to support parents as they face the difficult task of disclosing genetic risk to their children, potentially through providing quality written information or additional counseling sessions to help facilitate discussion.
Timing of testing and the potential reproductive implications for their daughters was an identified theme. Thus, discussion of reproductive timing and family planning should be included in the genetic counseling session and will allow for the genetic counselor to understand if timing of testing, related to the chance of pregnancy, is influencing the family discussion of carrier testing.
Prior studies have shown that communication of carrier status occurs within the context of the family and have suggested the importance of health care providers assisting with this communication (Sorenson et al. 2003) . Our study supports the common views of genetic counselors' that family context plays an important role in decision making and that exploration with families about how they may assist in the communication with at-risk daughters can provide beneficial support and autonomy. Figure 1 provides suggested discussion points for use by genetic counselors to aid in this Fig. 1 Genetic counseling discussion points for DMD carrier testing conversation with a family being seen for DMD carrier testing of an at-risk daughter who is a minor. Discussing family communication may allow genetic counselors to be incorporated into this discussion, instead of being seen as an obstacle to testing.
Study Limitations and Research Recommendations
The initial goal of this study was to collect data from various family members: mothers, fathers, and sisters of boys with DMD. However, the majority of participants were mothers of boys with DMD such that the one father and three sisters were excluded. This may limit the generalizability of the findings. The sample size is small, which may have precluded finding differences between subgroups, such as between mothers with and without daughters. The participants tended to be of a lower educational level and were predominantly Caucasian, which further limits generalizability of the findings. The health status of the affected individual and whether he was living or deceased was not collected by this survey. Collection of these data would have allowed for comparison of responses by those mothers whose sons were deceased and those who were living. Future research exploring similarities and differences between the experiences of these two would provide additional insight into the experience of communication around carrier status determination.
The perspective of practicing genetic counselors on carrier testing for at risk female minors would also provide insight into the practice of carrier testing. In addition, future studies on the implementation of the genetic counseling practice suggestions mentioned above could provide information about the impact of implementation of those guidelines on patient satisfaction. The current study focused on a lethal X-linked disorder, DMD. Similar studies focusing on other X-linked conditions would provide the opportunity to compare and contrast the findings of this study.
Conclusions
The results of this study provide insights to consider in genetic counseling of individuals with a family history of DMD. Participants felt carrier testing as a minor was favorable for reproductive reasons, but caution should be taken to recognize the maturity of the individual. Open and honest communication of disease information and carrier risk from a young age was of great importance to participants who said age should be taken into consideration regarding the content of the discussion, not for timing of the discussion itself. Finally, participants indicated that genetic counselors should respect the autonomy of the individual. Effective genetic counseling can be achieved when balancing general ethical principles with the specific needs of the counselee(s). Incorporating these ideals into clinical practice will improve the genetic counseling session and increase patient satisfaction.
